BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200928
DTEND;VALUE=DATE:20201002
DTSTAMP:20260405T085831
CREATED:20200819T142611Z
LAST-MODIFIED:20200924T151406Z
UID:4283-1601251200-1601596799@carb-x.org
SUMMARY:World Vaccine Congress
DESCRIPTION:CARB-X speakers include Nadia Cohen\, Alliance Manager. \nThe World Vaccine Congress is an award-winning series of conferences and an exhibition that has grown to become the largest and most established vaccine meeting of its kind across the globe. Due to the global pandemic\, we have made a decision to run the 2020 congress VIRTUALLY. To mobilize\, coordinate and align funding to enable the research needed to tackle this crisis and stop the outbreak\, and commit with our experts how you can learn mechanisms for continuing scientific interactions and collaborations\, now and beyond the congress.\n  \nClick here to view the agenda.\nClick here to learn more.\nClick here to register. \nNadia Cohen will be participating in the panel\, World Vaccine Congress: Success case study 2 – Partnering with a non-profit for the first toxoid based multivalent vaccine for MRSA\, on September 29 at 2:40 pm – 3:10 pm ET.
URL:https://carb-x.org/event/world-vaccine-congress/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201002
DTEND;VALUE=DATE:20201003
DTSTAMP:20260405T085831
CREATED:20200824T155054Z
LAST-MODIFIED:20200924T135933Z
UID:4304-1601596800-1601683199@carb-x.org
SUMMARY:Boston Area Antimicrobial Resistance Network (BAARN) Meeting
DESCRIPTION:CARB-X speakers include Su Chiang\, Alliance Manager. \nThe 7th BAARN meeting will bring together the leading voices in academia and industry to addresss a defining global health crisis of our age: antibiotic resistant infection. \nThis year will be BAARN’s inaugural virtual meeting. We are using online platforms to present an amazing lineup of researchers and innovators\, accessible to anyone with an internet connection. The event will stream on YOUTUBE LIVE. Zoom and YouTube Live links will be sent upon registration. \nThis event is co-coordinated by the Harvard Microbial Sciences Initiative and the Harvard Infectious Disease Institute. \nTo learn more\, click here. \nTo register\, click here.
URL:https://carb-x.org/event/boston-area-antimicrobial-resistance-network-baarn-meeting/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201008
DTEND;VALUE=DATE:20201010
DTSTAMP:20260405T085831
CREATED:20200817T133102Z
LAST-MODIFIED:20200924T145717Z
UID:4270-1602115200-1602287999@carb-x.org
SUMMARY:World Antimicrobial Resistance Congress 2020
DESCRIPTION:Erin Duffy\, CARB-X Chief of R&D\, is the chairperson of the event as well as a participant in a number of panels.  Other participants from CARB-X include Kevin Outterson (Executive Director)\, Richard Alm (Therapeutic R&D Alliance Director)\, Ed Buurman (Prevention R&D Alliance Director) and Betsy Wonderly Trainor (Diagnostic R&D Alliance Director).\n\nThe 6th annual World Antimicrobial Resistance Congress will be held virtually October 8-9\, 2020. It will showcase more than 250 presentations\, including speakers from CARB-X funded companies\, Forge and Entasis. \nAnti-microbial resistance continues to grow as a critical healthcare crisis globally. The number of deaths attributed to this epidemic is exponentially increasing\, and most measures and policies to combat AMR are deemed insufficient.Since 2015\, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet\, brainstorm ideas and formulate initiatives that can effectively tackle this pressing issue. \nIndustry leaders\, innovative technology and solution providers\, public authorities\, international organizations\, infectious disease clinicians\, pharmacists and microbiologists are some of the 1\,000+ attendees from over 50 countries who will gather virtually this October 2020 at the World Anti-Microbial Resistance Congress. \nIf you work in these key areas of AMR\, then you must attend the World Anti-Microbial Resistance Congress 2020! \n\nClick here for more information.\nClick here to register.
URL:https://carb-x.org/event/world-antimicrobial-resistance-congress-2020/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201015T090000
DTEND;TZID=America/New_York:20201015T100000
DTSTAMP:20260405T085831
CREATED:20200916T174706Z
LAST-MODIFIED:20200916T174706Z
UID:4345-1602752400-1602756000@carb-x.org
SUMMARY:Antimicrobial Resistance Fighter Coalition Webinar: Prevention is stronger than a cure
DESCRIPTION:AMR in the Light of COVID-19 – A Webinar Series\nEach of us is now living in a world with a nearly untreatable virus – but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to kill them. COVID-19 foreshadows a grim future if we do not mobilize a global response to the growing threat of antimicrobial resistance (AMR). Through a four-part series\, global experts will discuss how the COVID-19 pandemic could reshape strategies for combating antimicrobial resistance around the world. \nAbout this Webinar:\nPreventing drug resistant infections reduces the use of antibiotics and improves patient outcomes. Infection control practices\, from simple hand-washing to global vaccination\, and the use of effective infection prevention measures are key tools to combat COVID-19 and AMR. How has the COVID-19 pandemic informed our infection prevention efforts for healthcare systems and individuals around the world? \nTo learn more about the Antimicrobial Resistance Fighter Coalition\, click here.\nTo learn more about this webinar series\, click here.\nTo register for this webinar\, click here.
URL:https://carb-x.org/event/antimicrobial-resistance-fighter-coalition-webinar-prevention-is-stronger-than-a-cure/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201019
DTEND;VALUE=DATE:20201022
DTSTAMP:20260405T085831
CREATED:20200924T150127Z
LAST-MODIFIED:20200924T150127Z
UID:4402-1603065600-1603324799@carb-x.org
SUMMARY:5th Microbiome Movement - Drug Development Summit 2020
DESCRIPTION:The study of the human microbiome remains one of the most exciting frontiers in modern medicine that if targeted correctly\, has the potential to benefit millions of patients suffering from numerous diseases. However\, the potential for effective medicines powered by the microbiome is matched by the unique challenges in developing them. \nThe Microbiome Movement – Drug Development Summit returns as the “must attend meeting for the translational microbiome community” to help cutting-edge pharmaceutical and academic researchers pursue the causal role of the human microbiome in disease to help deliver a new generation of targeted therapeutics\, biomarker and diagnostics that demonstrate consistent clinical outcomes and predictabe MoAs. \nSo whether you’re part of a microbiome-focused biotech\, a pharmaceutical organization assessing this exciting field\, or an academic researcher with breakthrough findings\, join the Microbiome Movement as we explore the global advances in translational microbiome research\, and meet like-minded peers who are continuing to understand the causal and therapeutic potential of the ‘second genome’. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/5th-microbiome-movement-drug-development-summit-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201019T040500
DTEND;TZID=America/New_York:20201019T040500
DTSTAMP:20260405T085831
CREATED:20200916T173318Z
LAST-MODIFIED:20200924T150708Z
UID:4341-1603080300-1603080300@carb-x.org
SUMMARY:World Vaccine Congress Europe: Changing the paradigm and finding a sustainable way to tackle AMR - The need for alternatives to antibiotics
DESCRIPTION:CARB-X speakers include Ed Buurman\, Alliance Director. \nTopics covered include: \n\nHow big is the problem economically speaking?\nShould we phase out broad-spectrum antibiotics?\nProgrammatic & technical challenges\nWhat can vaccines bring?\n\nClick here to view the agenda.\nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/world-vaccine-congress-europe-changing-the-paradigm-and-finding-a-sustainable-way-to-tackle-amr-the-need-for-alternatives-to-antibiotics/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201021
DTEND;VALUE=DATE:20201026
DTSTAMP:20260405T085831
CREATED:20200908T155407Z
LAST-MODIFIED:20200908T160006Z
UID:4321-1603238400-1603670399@carb-x.org
SUMMARY:IDWeek 2020
DESCRIPTION:To learn more\, click here.\nTo view the program\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/idweek-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201026
DTEND;VALUE=DATE:20201030
DTSTAMP:20260405T085831
CREATED:20200908T155855Z
LAST-MODIFIED:20200908T161523Z
UID:4323-1603670400-1604015999@carb-x.org
SUMMARY:38th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2020)
DESCRIPTION:The 38th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2020) will be held on 26-29 October 2020 as a fully virtual meeting. \nThe organization of the meeting is a joint effort of ESPID members from the Netherlands. The ESPID forms the basis for investigators interested in infectious diseases in children and infection prevention in childhood. The main intent of the meeting is to bring together the most prominent researchers in and relevant to the field of paediatric infectious diseases and immunology. The meeting will provide an opportunity to exchange knowledge and generate new ideas in a relaxed\, smart albeit casual atmosphere. \nTo learn more\, click here.\nTo view the program\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/38th-annual-meeting-of-the-european-society-for-paediatric-infectious-diseases-espid-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201028
DTSTAMP:20260405T085831
CREATED:20200908T160156Z
LAST-MODIFIED:20201020T143659Z
UID:4326-1603756800-1603843199@carb-x.org
SUMMARY:BARDA Industry Day
DESCRIPTION:BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities\, interact with BARDA and ASPR staff\, and network with public and private sector colleagues working in the Health Security space. This year\,  BARDA Industry Day 2020 will be virtual and will feature one day of exciting speakers\, breakout sessions\, and valuable networking opportunities!  The primary mission of BARDA’s industry day is to advance innovation and development of medical countermeasures\, bring together potential collaborators from across organizations\, share our accomplishments among our stakeholders\, and provide BARDA’s vision for the upcoming year’s priorities. \nBARDA\, through the CARB-X and Drive programs\, is supporting a networks of wrap-around-service-oriented accelerators that can be leveraged to prepare partners for donor funding. The hope is to fill and maintain a pipeline of partners ready and able to apply for advanced research support while bolstering the market of life-saving countermeasures. DRIVE and CARB-X will organize a panel of BARDA supported accelerators who will describe how “wrap-around services” have actually lead to better products (fitting the BID theme of ‘responding together’. At the end of the panel\, we will moderate a Q&A with audience members. Promotional material from other accelerators will be made available digitally for audience members. \nTo learn more\, click here.
URL:https://carb-x.org/event/barda-industry-day-2/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201028T040000
DTEND;TZID=America/New_York:20201028T053000
DTSTAMP:20260405T085831
CREATED:20201026T142510Z
LAST-MODIFIED:20201026T142557Z
UID:4512-1603857600-1603863000@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – Developing antibiotics for children – medical need and regulatory challenges
DESCRIPTION:Speakers: \nPhoebe Williams\, Sydney Children’s Hospital and University of Sydney (Australia)\, will discuss: \n\nStatus quo – what antibiotics do we have (left) for children and babies\nWhere is the biggest medical need?\nChallenges of clinical trials in children – the clinicians perspective\nWhat impact will new drugs have in day-to-day practice and how does this depend on the setting (e.g. LMICs vs. high-income; community vs. hospital)?\n\nIrja Lutsar\, University of Tartu (Estonia)\, will discuss: \n\nClinical development of antibiotics for children; incl. new formulations of existing antibiotics including general regulatory requirements\nBrief overview of the type of data required for a new antibiotic for paediatric use; i.e. PK and other data\nChallenges of clinical trials in children and babies – the drug developers/regulatory perspective\n\nModerator: Sally Ellis (GARDP)  \nThe presentations will be followed by a Q&A session. \nTo learn more\, click here. 
URL:https://carb-x.org/event/live-webinar-gardp-revive-saving-childrens-lives-treating-neonatal-sepsis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20201029T160000
DTEND;TZID=Europe/Paris:20201029T180000
DTSTAMP:20260405T085831
CREATED:20201013T195519Z
LAST-MODIFIED:20201013T195519Z
UID:4453-1603987200-1603994400@carb-x.org
SUMMARY:Interdisciplinary Course on Antibiotics and Resistance (ICARe) Webinar:
DESCRIPTION:Panelists include Erin Duffy\, CARB-X Chief of R&D \nPlease join us for a special ICARe webinar in light of the course’s 5th anniversary.  This two-hour event\, hosted by ICARe director Patrice Courvalin (Institut Pasteur\, France)\, will feature four 20-minute presentations from leading experts in antimicrobial resistance and antibiotic discovery research. Presentations will follow with a 30-minute panel discussion. \nThe webinar schedule is as follows: \n\n4:00: Patrice Courvalin (Institut Pasteur\, France) – Introduction\n4:05: Helen Boucher (Tufts Medical Center\, USA) – “Syndemics of AMR and COVID”\n4:25: Gerry Wright (McMaster University\, Canada) – “What’s new in antibiotic resistance?”\n4:45: Erin Duffy (CARB-X\, USA) – “Innovation in antibiotic discovery”\n5:05: John Rex (F2G\, UK)- “Prospects and remaining challenges in antibiotic development”\n5:25: Panel Discussion\n5:55: Patrice Courvalin (Institut Pasteur\, France) – Closing Remarks\n\nTo learn more\, click here.\nTo register\, click here.   \nAfter registering\, you will receive a confirmation email containing information about joining the webinar. Please note that the webinar start time is in Paris Time.​
URL:https://carb-x.org/event/interdisciplinary-course-on-antibiotics-and-resistance-icare-webinar/
LOCATION:Webinar
END:VEVENT
END:VCALENDAR